Inhibitory Antibodies
-
F1921 Anti-ANGPT2 Antibody (Roche patent anti-ANG-2)Summary: Anti-ANGPT2 Antibody (Roche patent anti-ANG-2) -
F1922 Anti-ANGPTL4 Antibody (Nanyang Tech.U. patent anti-ANGPTL4)Summary: Anti-ANGPTL4 Antibody (Nanyang Tech.U. patent anti-ANGPTL4) -
F1923 Anti-ASIC1 Antibody (Regeneron patent anti-ASIC1)Summary: Anti-ASIC1 Antibody (Regeneron patent anti-ASIC1) -
F1924 Anti-AXL/UFO Antibody (Tilvestamab-MMAE)Summary: Anti-AXL/UFO Antibody (Tilvestamab-MMAE) -
F1925 Anti-B7-H3/CD276 Antibody (Trellis patent anti-B7-H3)Summary: Anti-B7-H3/CD276 Antibody (Trellis patent anti-B7-H3) -
F1926 Anti-B7-H4/VTCN1 Antibody (Millennium patent anti-B7-H4)Summary: Anti-B7-H4/VTCN1 Antibody (Millennium patent anti-B7-H4) -
F1927 Anti-B7-H6/NCR3LG1 Antibody (Dartmouth patent anti-B7-H6)Summary: Anti-B7-H6/NCR3LG1 Antibody (Dartmouth patent anti-B7-H6) -
F1928 Anti-Bcl-2 Antibody (U.Toronto patent anti-Bax)Summary: Anti-Bcl-2 Antibody (U.Toronto patent anti-Bax) -
F1929 Anti-BST2/CD317 Antibody (SBI Biotech patent anti-BST2)Summary: Anti-BST2/CD317 Antibody (SBI Biotech patent anti-BST2) -
F1930 Anti-CA9/CAIX Antibody (Girentuximab-MMAE)Summary: Anti-CA9/CAIX Antibody (Girentuximab-MMAE)